ChemoMetec Past Earnings Performance
Past criteria checks 3/6
ChemoMetec has been growing earnings at an average annual rate of 32%, while the Life Sciences industry saw earnings growing at 19.1% annually. Revenues have been growing at an average rate of 22.8% per year. ChemoMetec's return on equity is 28.8%, and it has net margins of 35.8%.
Key information
32.0%
Earnings growth rate
30.6%
EPS growth rate
Life Sciences Industry Growth | 26.8% |
Revenue growth rate | 22.8% |
Return on equity | 28.8% |
Net Margin | 35.8% |
Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How ChemoMetec makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 402 | 144 | 155 | 0 |
30 Sep 23 | 423 | 161 | 150 | 0 |
30 Jun 23 | 444 | 179 | 144 | 0 |
31 Mar 23 | 453 | 179 | 162 | 0 |
31 Dec 22 | 461 | 180 | 171 | 0 |
30 Sep 22 | 445 | 170 | 166 | 0 |
30 Jun 22 | 428 | 159 | 161 | 0 |
31 Mar 22 | 393 | 145 | 147 | 0 |
31 Dec 21 | 358 | 131 | 133 | 0 |
30 Sep 21 | 320 | 110 | 125 | 0 |
30 Jun 21 | 281 | 88 | 118 | 0 |
31 Mar 21 | 262 | 81 | 108 | 0 |
31 Dec 20 | 243 | 74 | 98 | 0 |
30 Sep 20 | 229 | 67 | 98 | 0 |
30 Jun 20 | 214 | 59 | 97 | 0 |
31 Mar 20 | 206 | 54 | 99 | 0 |
31 Dec 19 | 197 | 48 | 101 | 0 |
30 Sep 19 | 186 | 45 | 98 | 0 |
30 Jun 19 | 176 | 42 | 94 | 0 |
31 Mar 19 | 158 | 37 | 86 | 0 |
31 Dec 18 | 141 | 33 | 78 | 0 |
30 Sep 18 | 127 | 25 | 74 | 0 |
30 Jun 18 | 113 | 18 | 69 | 0 |
31 Mar 18 | 107 | 15 | 69 | 0 |
31 Dec 17 | 102 | 13 | 69 | 0 |
30 Sep 17 | 96 | 10 | 66 | 0 |
30 Jun 17 | 90 | 7 | 64 | 0 |
31 Mar 17 | 88 | 6 | 61 | 0 |
31 Dec 16 | 85 | 5 | 59 | 0 |
30 Sep 16 | 85 | 8 | 54 | 0 |
30 Jun 16 | 85 | 10 | 50 | 0 |
31 Mar 16 | 80 | 11 | 47 | 0 |
31 Dec 15 | 75 | 12 | 44 | 0 |
30 Sep 15 | 68 | 10 | 42 | 0 |
30 Jun 15 | 61 | 8 | 41 | 0 |
31 Mar 15 | 56 | 5 | 38 | 0 |
31 Dec 14 | 51 | 3 | 36 | 0 |
30 Sep 14 | 48 | 2 | 35 | 0 |
30 Jun 14 | 45 | 1 | 33 | 0 |
31 Mar 14 | 44 | 1 | 32 | 0 |
31 Dec 13 | 43 | 1 | 31 | 0 |
30 Sep 13 | 42 | 1 | 30 | 0 |
30 Jun 13 | 41 | 0 | 29 | 0 |
Quality Earnings: CHY has high quality earnings.
Growing Profit Margin: CHY's current net profit margins (35.8%) are lower than last year (39%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CHY's earnings have grown significantly by 32% per year over the past 5 years.
Accelerating Growth: CHY's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CHY had negative earnings growth (-20%) over the past year, making it difficult to compare to the Life Sciences industry average (6.5%).
Return on Equity
High ROE: CHY's Return on Equity (28.8%) is considered high.